OMEGA-3 FATTY ACIDS REDUCE INFLAMMATION IN PATIENTS WITH ASTHMA

Natural asthma therapies? Inflammation is the  cause  for most asthma sufferers. Dr. Susarla

A recent study found that high quality omega-3 fatty acids (17-HDHA) may decrease the inflammatory immune system response related to allergic asthma, and might be an effective alternative to corticosteroids for patients with mild asthma.

“While corticosteroids can be effective at suppressing chronic inflammation, systemic or [oral corticosteroids] also have deleterious side effects, including weight gain, osteoporosis, and growth retardation in children,” the researchers wrote.

Specialized proresolving mediators, such as omega-3 fatty acids, have been shown in animal models to reduce inflammation in chronic inflammatory diseases.

To investigate their effects in patients with asthma, researchers collected blood samples from 17 patients with asthma taking inhaled corticosteroids, with β2-agonists as needed; 3 of the 17 participants were taking high dosages of oral corticosteroids. Blood samples from healthy donors were also collected.

Researchers isolated peripheral blood B cells and treated them with either 17-HDHA or resolvin D1 (RvD1) using cells from at least 3 participants to test that effects of omega-3 fatty acids on immunoglobulin E (IgE) production in B cells. In one experiment, researchers tested the effects of corticosteroids on the ability of 17-HDHA to reduce inflammation.

Their findings showed that 17-HDHA and RvD1 reduced the level of IgE antibodies in blood samples, indicating a reduction in the antibodies that cause allergic reactions and asthma symptoms.

However, the results were not found in samples from participants on high doses of oral corticosteroids as researchers discovered that the steroids blocked the beneficial effects of omega-3 fatty acids in participants with severe asthma. 

“Our results suggest that [specialized proresolving mediators] are important potential therapeutics for most patients with allergic asthma. Further, our results highlight that immunosuppressive therapies like [oral corticosteroids] also suppress endogenous resolution pathways and suggest one method by which [oral corticosteroids] may actually exacerbate allergic diseases,” the researchers concluded.

Article linked here.

Strange but true finding, animal airways have "taste buds" that allow them to react to exceedingly bitter substances -- causing the airways to relax, not unlike an asthma inhaler.  Dr. Susarla

Could a bitter compound give clues about asthma?

For a long time, scientists thought the taste receptors that signal sweet, bitter, or salty were found only in our taste buds. Then, things started to get weird.

Six years ago, researchers found taste receptors in the cells of the gut. Even more bizarre, scientists found them in cells that line the airway, and in the muscles that contract during an asthma attack. Basic scientific research began to suggest that bitter chemicals had potential as an asthma treatment. That is when Ronghua ZhuGe, a University of Massachusetts Medical School microbiologist, began to pay attention.

ZhuGe studies cell signaling involved in muscle function, a process that helps regulate blood pressure or airway constriction. He was intrigued when he read about experiments that showed that bitter compounds could cause those muscle cells to relax, pointing to a potential way to quell an asthma attack.

In that initial paper, the researchers called it a paradoxical result. They expected the bitter compounds would have the opposite effect, causing airway cells to contract. That would add to the problems patients experience in diseases caused by airway obstruction, such as asthma. But instead, bitter substances caused the cells to relax. ZhuGe decided to study how the compounds had that effect.

In a study published Tuesday in the journal PLOS Biology, ZhuGe and colleagues tease out the precise cellular mechanisms at work when bitter stuff, such as quinine and denatonium — ZhuGe says it is the most bitter compound that exists — are administered to those airway cells. The scientists took freshly procured muscle airway cells from mice and carefully figured out the complicated signaling that results in the relaxation of the cells. That is the goal with asthma medications, called bronchodilators.

“Definitely, we see a great potential to develop a new class of bronchodilators,” ZhuGe said. “When we compare how effective those compounds are to relax airways, we found we can relax them more completely compared” to existing treatments.

ZhuGe said the prospects are particularly exciting because there are so many bitter compounds that could be tried as potential new asthma treatments. The search will be guided, he hopes, by a more precise understanding of the mechanism at play when airway cells relax in response to a bitter stimulant.

But why did bitter taste receptors end up in our lungs in the first place? ZhuGe said his guess is it could be a protective mechanism; perhaps it is advantageous to have cells relax instead of contract when inhaling a bitter compound.

Read article here.